Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 33342-215

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 33342-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

505 (Sevelamer Carbonate Container 270s)

This is a description of Sevelamer Carbonate Tablets manufactured by Macleods Pharma USA. Each film-coated tablet contains 800mg of Sevelamer carbonate and the usual dosage should be determined by a healthcare provider. It is recommended to store the product at 20° to 25°C and dispense in a tight container to protect from moisture. The product comes in a 270 tablet pack and must be kept within the USP Controlled Room Temperature range of 15° to 30°C. The Code No. for the product is DD/DRUGS/DD/375.*

FDA Label Image

Sevelamer-car-structure (Sevelamer Carbonate Fig 1)

FDA Label Image

Figure-2 (Sevelamer Carbonate Fig 2)

FDA Label Image

Figure-3 (Sevelamer Carbonate Fig 3)

This is a study report describing the reduction in serum phosphorus in patients using Sevelamer Hydrochloride and an active control. The percentage of patients who experienced reduction from baseline, as well as improvement or worsening, is provided along with a graph showing the reduction over time.*

FDA Label Image

Figure-4 (Sevelamer Carbonate Fig 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.